CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
62 hedge funds and large institutions have $1.37B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
62
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.7M | |
| 2 | +$12.8M | |
| 3 | +$11.1M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$11M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$5.39M |
Top Sellers
| 1 | -$11.4M | |
| 2 | -$8.24M | |
| 3 | -$6.63M | |
| 4 |
DM
Deerfield Management
New York
|
-$6.38M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$4.52M |